摘要
目的 探讨β～肾上腺素能兴奋剂(舒喘灵)对血液透析中高钾血症患者血钾浓度的影响。方法30例维持血透病人随机分为治疗组和对照组,所有病人每周碳酸氢盐血透2次,每次4～4.5h,血流量200～250ml/min,实验4周内完成,实验组15例前两周口服舒喘灵2mg,每12h一次。对照组不用舒喘灵。所有病例在前两周和第4周的血透前用电极法测定血钾浓度。结果 实验组病人血钾浓度降低,与对照组比较P<0.01。结论舒喘灵可降低和稳定维持性血透病人的血钾浓度。
objetive To investigste the influence of albuterol on potassium concentration in hemodialysis patients with hyperkalemia. Methods 30 patients were divided randomly into experimental group and control group, All patients were hemodialized 2 times per week using bi-carbonates inbiood volume 200 -250ml/min for 4 -4. 5hours, The paeitnes in experimental group took albuterol orally 2mg per 12 hours at the first two weeks while the patients in control group didn't I. And the concentration of potassium were measured by electrometry, at the first 2 weeks and the forth week. Results The concentration of potassium in experimental group was lowar than that of control group (P<0. 01), Conclusion Albuterol can lower and stablize potassium concentration in patients on hemodialysis.
出处
《湖北民族学院学报（医学版）》
2002年第3期15-16,共2页
Journal of Hubei Minzu University(Medical Edition)
